insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.04
arrow_downward
-3.70%(-0.040) 1D
ኖቬም 13, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
328.88 ሺ
52-wk high
US$4.34
52-wk low
US$0.96
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
328.88 ሺ
52-wk high
US$4.34
52-wk low
US$0.96
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
BigGo Finance
·
ከ38 ደቂቃዎች በፊት
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TheStreet
·
ከ1 ሰዓት በፊት
Goldman Sachs reset S&P 500 price target for 2027
TradingKey
·
ከ11 ሰዓቶች በፊት
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
ከ2 ቀናት በፊት
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com